Loading company details...
Latest Form 4 (Oct 7, 2026): Bryan F. Cox (Chief of Research): Sale of 296 shares, $1.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Bryan F. Cox, Chief of Research | Sale | 296 | $1.3K |
| Oct 7, 2026 | Richard Marshak, Chief Commercial Officer | Sale | 325 | $1.4K |
| Oct 7, 2026 | Jennifer Stevens, Chief Regulatory Officer | Sale | 316 | $1.4K |
| Oct 7, 2026 | Mary T. Szela, CEO and President | Tax Withholding | 2,693 | $11.8K |
| Jul 6, 2026 | David Patience, Chief Financial Officer | Tax Withholding | 14,650 | $65.3K |
| Jul 1, 2026 | Mary T. Szela, CEO and President | Grant/Award | 3,990 | $15.4K |
| Jul 1, 2026 | Richard Marshak, Chief Commercial Officer | Grant/Award | 561 | $2.2K |
| Jun 29, 2026 | Richard Henry Marshall, Chief Medical Officer | Grant/Award | 60,000 | n/a |
| May 19, 2026 | Richard Marshak, Chief Commercial Officer | Sale | 543 | $1.4K |
| May 18, 2026 | Mats Wahlstrom | Purchase | 60,000 | $151.8K |